Menu
Back to Journals » OncoTargets and Therapy » Volume 16
Original Research
Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension (NDLS) versus Conventional Docetaxel as Neoadjuvant and Adjuvant Therapy for Primary Operable Breast Cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 3,288 | Dovepress* | 3,007+ | 66 | 3,073 | |
| PubMed Central* | 281 | 53 | 334 | ||
| Totals | 3,288 | 119 | 3,407 | ||
| *Since 1 April 2023 | |||||
View citations on PubMed Central and Google Scholar